Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrashekhar Korgaonkar

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Biology|December 12, 2001
ARF function does not require p53 stabilization or Mdm2 relocalizationChandrashekhar Korgaonkar, Lili Zhao, Modestos Modestou, et al.
Molecular Cancer Research : MCR|January 31, 2003
Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathwaysLili Zhao, Tina Samuels, Sarah Winckler, et al.
Molecular and Cellular Biology|February 3, 2005
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its functionChandrashekhar Korgaonkar, Jussara Hagen, Van Tompkins, et al.
The Journal of Antibiotics|October 23, 2023
Potent Rifampicin derivatives can clear MRSA infections at single low doses when concomitantly dosed with VancomycinThomas Nittoli, Anna Brotcke Zumsteg, Abira Bandyopadhyay, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Biology|December 12, 2001
ARF function does not require p53 stabilization or Mdm2 relocalizationChandrashekhar Korgaonkar, Lili Zhao, Modestos Modestou, et al.
Molecular Cancer Research : MCR|January 31, 2003
Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathwaysLili Zhao, Tina Samuels, Sarah Winckler, et al.
Molecular and Cellular Biology|February 3, 2005
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its functionChandrashekhar Korgaonkar, Jussara Hagen, Van Tompkins, et al.
The Journal of Antibiotics|October 23, 2023
Potent Rifampicin derivatives can clear MRSA infections at single low doses when concomitantly dosed with VancomycinThomas Nittoli, Anna Brotcke Zumsteg, Abira Bandyopadhyay, et al.
Pageof 1